SII Investments’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-19,164
Closed -$2.67M 180
2017
Q4
$2.67M Sell
19,164
-32,265
-63% -$4.49M 0.28% 74
2017
Q3
$6.69M Buy
51,429
+267
+0.5% +$35.4K 0.38% 52
2017
Q2
$6.75M Sell
51,162
-4,849
-9% -$619K 0.42% 48
2017
Q1
$6.96M Sell
56,011
-88
-0.2% -$10.5K 0.48% 43
2016
Q4
$6.48M Buy
56,099
+1,610
+3% +$186K 0.48% 43
2016
Q3
$6.44M Sell
54,489
-626
-1% -$75.9K 0.49% 42
2016
Q2
$6.66M Buy
55,115
+3,105
+6% +$353K 0.54% 45
2016
Q1
$5.64M Buy
52,010
+5,101
+11% +$528K 0.53% 45
2015
Q4
$4.82M Sell
46,909
-4,708
-9% -$473K 0.61% 36
2015
Q3
$4.8M Sell
51,617
-7,716
-13% -$746K 0.55% 41
2015
Q2
$5.78M Sell
59,333
-4,898
-8% -$490K 0.68% 32
2015
Q1
$6.47M Buy
64,231
+1,649
+3% +$168K 0.78% 27
2014
Q4
$6.53M Sell
62,582
-3,880
-6% -$409K 0.86% 24
2014
Q3
$7.1M Buy
66,462
+2,374
+4% +$246K 0.95% 19
2014
Q2
$6.69M Buy
64,088
+2,137
+3% +$216K 0.96% 19
2014
Q1
$5.55M Sell
61,951
-272
-0.4% -$25.2K 1.03% 17
2013
Q4
$5.67M Sell
62,223
-352
-0.6% -$32.4K 1.01% 18
2013
Q3
$5.44M Sell
62,575
-631
-1% -$56.6K 1.29% 13
2013
Q2
$5.44M Buy
+63,206
New +$5.36M 1.17% 14

Other funds holding JNJ

SII Investments's JNJ Position: Q1 2018 in Review

SII Investments sold out of Johnson & Johnson (JNJ) in Q1 2018, closing a stake of 19,164 shares — an estimated $2.67M sold.

SII Investments first reported a position in JNJ in Q2 2013 and held it in 19 quarters. The position peaked at $7.1M in Q3 2014. 2,597 funds tracked by Wall St. Rank hold JNJ as of Q1 2018.

  • SII Investments reported no remaining Johnson & Johnson position as of Q1 2018 after selling out during the quarter.
  • SII Investments sold 19,164 Johnson & Johnson shares in Q1 2018, an estimated $2.67M.
  • SII Investments first reported a position in Johnson & Johnson in Q2 2013 and held it in 19 quarters.
  • SII Investments's Johnson & Johnson position peaked at $7.1M in Q3 2014.
  • 2,597 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2018.

Based on SII Investments's 13F filing for Q1 2018.